Stride (LRN) is positioned for a "beat and raise" when it announces its fiscal Q3 results on April 29 as strong enrollment growth during the quarter is expected to exceed consensus and lead to a guidance increase, Morgan Stanley said in a Monday note.
"We think LRN's guidance and consensus estimates are too low, and expect positive revisions following the quarter," said the investment firm. Morgan Stanley estimates 237,000 average enrollments for the company in fiscal Q3, about a 6,000 sequential increase compared with the consensus of a 3,000 increase.
Stride, however, has "low visibility into forward enrollment growth sustainability" and the company's lack of disclosures affects investor confidence in its momentum, Morgan Stanley noted.
Morgan Stanley raised its price target on Stride stock to $141 from $117 and reiterated its equal-weight rating on the company.
Price: 135.38, Change: -0.49, Percent Change: -0.36
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.